Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients

References

• Stracquadanio M , Ciotta L. Metabolic aspects of PCOS. Berlin, Germany: Springer Editore; 2015.
   Google Scholar
• Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:265–93.
   PubMed Web of Science ®Google Scholar
• Achard MC , Thyers MJ. Le virilisme pilaire et son association a’ l’insuffisance glycolytique (diabe’te des femmes a barbe). Bull Acad Natl Med 1921;86:51–64.
   Google Scholar
• Carmina E , Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999;84:1897–9.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E , Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33:981–1030.
   PubMed Web of Science ®Google Scholar
• Hoffman LK , Ehrmann DA. Cardiometabolic features of polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2008;4:215–22.
   PubMedGoogle Scholar
• Dunaif A , Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;81:942–7.
   Google Scholar
• Ehrmann DA , Sturis J , Byrne MM , et al . Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995;96:520–7.
   PubMed Web of Science ®Google Scholar
• Mahabeer S , Jialal I , Norman RJ , et al . Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease. Horm Metab Res 1989;21:502–6.
   PubMed Web of Science ®Google Scholar
• O’Meara NM , Blackman JD , Ehrmann DA. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76:1241–7.
   PubMed Web of Science ®Google Scholar
• Dunaif A , Xia J , Book CB , et al . Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96:801–10.
   PubMed Web of Science ®Google Scholar
• Willis D , Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995;80:3788–90.
   PubMed Web of Science ®Google Scholar
• Munir I , Yen HW , Geller DH , et al . Insulin augmentation of 17β-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 2004;145:175–83.
   PubMed Web of Science ®Google Scholar
• Barbieri RL , Makris A , Ryan KJ. Effects of insulin on steroidogenesis in cultured porcine ovarian theca. Fertil Steril 1983;40:237–41.
   PubMed Web of Science ®Google Scholar
• Nestler JE , Strauss JF. III Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991;20:807–23.
   PubMed Web of Science ®Google Scholar
• Franks S , Gilling-Smith C , Watson H , Willis D . Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999;28:361–78.
   PubMed Web of Science ®Google Scholar
• Adashi EY , Hsueh AJ , Yen SS. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 1981;108:1441–9.
   PubMed Web of Science ®Google Scholar
• Dunaif A , Segal KR , Futterweit W , et al . Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165–74.
   PubMed Web of Science ®Google Scholar
• Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr 1986;6:563–97.
   PubMed Web of Science ®Google Scholar
• Schlemmer U , Frolich W , Prieto RM , Grases F. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res 2009;53:S330–S75.
   PubMed Web of Science ®Google Scholar
• Larner J , Brautigan DL , Thorner MO. D-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med 2010;16:543–52.
   PubMed Web of Science ®Google Scholar
• Croze ML , Soulage CO . Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95:1811–27.
   PubMed Web of Science ®Google Scholar
• Saltiel AR. Second messengers of insulin action. Diabetes Care 1990;13:244–56.
   PubMed Web of Science ®Google Scholar
• Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod BioMed Online 2016;33:770–80.
   PubMed Web of Science ®Google Scholar
• Parijat K , Rekha S , Madhusudan K. Gymnema sylvestre: a memoir. J Clin Biochem Nutr 2007;41:77–81.
   PubMed Web of Science ®Google Scholar
• Yoshikawa K , Kondo Y , Arihara S , Matsuura K. Antisweet natural products IX structures of gymnemic acids XV-XVIII from Gymnema sylvestre . Chem Pharm Bull 1993;41:1730–2.
   Web of Science ®Google Scholar
• Tiwari P , Mishra BN , Sangwan NS. Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. BioMed Res Int 2014;2014:830285.
   Web of Science ®Google Scholar
• Bone K. Gymnema: a key herb in the management of diabetes, in Phytotherapy Review and Commentary. National Institute of Herbalists, Exeter, UK: National Herbalists Association of Australia; 2002.
   Google Scholar
• Schacter M , Raziel A , Friedler S , et al . Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003;18:721–7.
   PubMed Web of Science ®Google Scholar
• Wijeyaratne CN , Nirantharakumar K , Balen AH , et al . Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol 2004;60:560–7.
   PubMed Web of Science ®Google Scholar
• El-Khairy L , Ueland PM , Nygard O , et al . Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine study. Am J Clin Nutr 1999;70:1016–24.
   PubMed Web of Science ®Google Scholar
• McFarlane SI , Banerji M , Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713–18.
   PubMed Web of Science ®Google Scholar
• House JD , Jacobs RL , Stead LM , et al . Regulation of homocysteine metabolism. Adv Enzyme Regul 1999;39:69–91.
   PubMedGoogle Scholar
• McCarty MF. Increased homocysteine associated with smoking, chronic inflammation and ageing may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypoth 2000;55:289–93.
   PubMed Web of Science ®Google Scholar
• Boxmeer JC , Steegers-Theunissen RPM , Lindemans J , et al . Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation. Hum Reprod 2008;23:2570–6.
   PubMed Web of Science ®Google Scholar
• Ebisch IM , Peters WH , Thomas CM , et al . Homocysteine, glutathione and related thiols affect fertility parameters in the (sub) fertile couple. Hum Reprod 2006;21:1725–33.
   PubMed Web of Science ®Google Scholar
• Nafiye Y , Sevtap K , Muammer D , et al . The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of non-obese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril 2010;93:1864–9.
   PubMed Web of Science ®Google Scholar
• Granata O , Carbone P, Mantovani A, et al. Istituto Superiore di Sanità. Prevenzione primaria delle malformazioni congenite: attività del Network Italiano Promozione Acido Folico. Vol. iii. Rome: Rapporti ISTISAN; 2013. 180 p.
   Google Scholar
• Nestler JE , Jakubowicz DJ , Reamer P , et al . Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 1999;340:1314–20.
   PubMed Web of Science ®Google Scholar
• Genazzani AD , Lanzoni C , Ricchieri F , Jasonni V. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:139–44.
   PubMed Web of Science ®Google Scholar
• Zacchè M , Caputo L , Filippis S , et al . Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:508–13.
   PubMed Web of Science ®Google Scholar
• Pizzo A , Laganà AS , Barbaro L. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol 2014;30:205–8.
   PubMed Web of Science ®Google Scholar
• Costantino D , Minozzi G , Minozzi F , Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 2009;13:105–10.
   PubMed Web of Science ®Google Scholar
• Gerli S , Mignosa M , Di Renzo GC. Effects of inositol on ovarian function and meta-bolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 2003;7:151–9.
   PubMedGoogle Scholar
• Papaleo E , Unfer V , Baillargeon JP , et al . Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 2007;23:700–3.
   PubMed Web of Science ®Google Scholar
• Gerli S , Papaleo E , Ferrari A , Di Renzo GC . Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci 2007;11:347–54.
   PubMed Web of Science ®Google Scholar
• Genazzani AD , Prati A , Santagni S , et al . Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. Gynecol Endocrinol 2012;28:969–73.
   PubMed Web of Science ®Google Scholar
• Prakash AO , Mathur S , Mathur R. Effect of feeding Gymnema sylvestre leaves on blood glucose in beryllium nitrate treated rats. J Ethnopharmacol 1986;18:143–6.
   PubMed Web of Science ®Google Scholar
• Tominaga M , Kimura M , Sugiyama K , et al . Effects of seishin-renshi-in and Gymnema sylvestre on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 1995;29:11–17.
   PubMed Web of Science ®Google Scholar
• Sahu NP , Mahato SB , Sarkar SK , Poddar G. Triterpenoid saponins from Gymnema sylvestre . Phytochemistry 1996;41:1181–5.
   PubMed Web of Science ®Google Scholar
• Wang Y , Dawid C , Kottra G , et al . Gymnemic acids inhibit sodium-dependent glucose transporter 1. J Agric Food Chem 2014;62:5925–31.
   PubMed Web of Science ®Google Scholar
• Assadi-Porter FM , Tonelli M , Maillet EL , et al . Interactions between the human sweet-sensing T1R2-T1R3 receptor and sweeteners detected by saturation transfer difference NMR spectroscopy. Biochimica Et Biophysica Acta 2010;1798:82–6.
   PubMed Web of Science ®Google Scholar
• Sanematsu K , Kusakabe Y , Shigemura N , et al . Molecular mechanisms for sweet-suppressing effect of gymnemic acids. J Biol Chem 2014;289:25711–20.
   PubMed Web of Science ®Google Scholar
• Bhansali S , Shafiq N , Pandhi P , et al . Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome. Indian J Med Res 2013;137:1174–9.
   PubMed Web of Science ®Google Scholar
• Mall GK , Mishra PK , Prakash V. Antidiabetic and hypolipidemic activity of Gymnema sylvestre in alloxan induced diabetic rats. Global J Biot Bioche 2009;4:37–42.
   Google Scholar
• Scalera V , Natuzzi D , Prezioso G. Myo-inositol transport in rat intestinal brush border membrane vesicles, and its inhibition by D-glucose. Biochim Biophys Acta 1991;1062:187–92.
   PubMed Web of Science ®Google Scholar
• Aouameu R. SMIT2 mediates all myo-inositol uptake in apical membranes of rat small intestine. Am J Physiol Gastrointest Liver Physiol 2007;293:G1300–7.
   PubMed Web of Science ®Google Scholar
• Lin X , Ma L , Fitzgerald RL , Ostlund RE. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Arch Biochem Biophys 2009;481:197–201.
   PubMed Web of Science ®Google Scholar
• Emoto M , Kanda H , Shoji T , et al . Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001;24:533–8.
   PubMed Web of Science ®Google Scholar
• Meigs JB , Jacques PF , Selhub J , et al . Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403–10.
   PubMed Web of Science ®Google Scholar
• De Pergola G , Pannacciulli N , Zamboni M , et al . Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women. Diabetes Nutr Metab 2001;14:253–8.
   PubMedGoogle Scholar
• Fonseca VA , Fink LM , Kern PA. Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 2003;167:105–9.
   PubMed Web of Science ®Google Scholar
• Setola E , Monti LD , Galluccio E , et al . Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004;151:483–9.
   PubMed Web of Science ®Google Scholar
• Liu WJ , Ma LQ , Liu WH , et al . Inhibition of hepatic Glycogen synthesis by hyperhomocysteinemia mediated by TRB3. Am J Pathol 2011;178:1489–99.
   PubMed Web of Science ®Google Scholar
• Najib S , Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001;27:85–91.
   PubMed Web of Science ®Google Scholar
• Najib S , Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 2005;34:119–26.
   PubMed Web of Science ®Google Scholar
• Ron D , Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519–29.
   PubMed Web of Science ®Google Scholar
• Wright AJA , King MJ , Wolfe CA , et al . Comparison of (6S)-5-methyltetrahydrofolic acid v. folic acid as the reference folate in longer-term human dietary intervention studies assessing the relative bioavailability of natural food folates: comparative change in folate status following a 16-week placebo-controlled study in healthy adults. Br J Nutr 2010;103:724–9.
   PubMed Web of Science ®Google Scholar
• Czeizel AE , Dudás I , Paput L , et al . Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab 2011;58:263–71.
   PubMed Web of Science ®Google Scholar
• Pietrzik K , Bailey L , Shane B , et al . Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2010;49:535–48.
   PubMed Web of Science ®Google Scholar
• Borradale DC , Kimlin MG. Folate degradation due to ultraviolet radiation: possible implications for human health and nutrition. Nutr Rev 2012;70:414–22.
   PubMed Web of Science ®Google Scholar